-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Erratum
Other
(1655) Views (354) Full article downloads
Authors: Rapidis A, Sarlis N, Lefebvre J-L, et al
Published Date February 2009
Volume 2008:4(6) Pages 1381 - 1381
DOI: http://dx.doi.org/10.2147/TCRM.S5436
Rapidis A, Sarlis N, Lefebvre J-L, et al. 2008. Docetaxel in the treatment of squamous cell carcinoma of the head and neck. Ther Clin Risk Manag, 4:865–886
Page 870, right column of text: TPF and PF were given for 3 cycles not 4 cycles.
Page 871, Table 2 caption should read: TAX 323: select efficacy and safety results.
Page 872, Table 3 caption should read: TAX 324: select efficacy and safety results.
Other articles by Professor Alexander Rapidis
Docetaxel in the treatment of squamous cell carcinoma of the head and neck- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Tenofovir-associated bone density loss
- The benefits and risks of testosterone replacement therapy: a review
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
